| Date | Title | Description |
| 08.01.2025 | FIRE1 Secures $120M for Heart Failure Management Platform | What You Should Know:
– FIRE1, a connected medical device company, announced it has secured $120M in funding to advance its mission to transform the lives of millions of people living with heart failure. The round was led by Polaris Partner... |
| 23.02.2024 | Reprieve Cardiovascular Revolutionizes Heart Failure Treatment with $42M Funding | Reprieve Cardiovascular, a Milford, MA-based company, secures $42M in Series A funding to advance intelligent fluid management for heart failure patients. Led by Lightstone Ventures and Sante Ventures, the funding will propel Reprieve's mis... |
| 22.02.2024 | Reprieve Cardiovascular Nabs $42M to Expand Intelligent Fluid Management for Heart Failure | What You Should Know:
– Reprieve Cardiovascular, a pioneer in personalized fluid management for acute decompensated heart failure (ADHF) emerges from stealth launching with $42M in Series A financing round.
– The Series A round was co-led b... |
| 26.06.2023 | Dutch-based Tagworks Pharmaceuticals raises €59.5M to design effective, safe systemic therapies | The Netherlands-based Tagworks Pharmaceuticals, a company that claims to be a pioneer of Click-to-Release chemistry to deliver effective and safer systemic therapies, announced on Thursday, June 22, that it has raised $65M (approximately €5... |
| 15.09.2022 | ClavystBio launches to translate life sciences breakthroughs into health impact | ClavystBio will invest and work with partners to accelerate life sciences commercialisation in Singapore through three pillars: collaborate, venture and build.
ClavystBio has committed US$220 million to date in investments to launch global ... |
| 14.09.2021 | Lightstone Ventures Raises $375 Million Fund | - |
| 14.09.2021 | Lightstone Ventures : Raises $375 Million Fund | MENLO PARK, Calif. and BOSTON, Sept. 14, 2021 /PRNewswire/ -- Lightstone Ventures today announced the closing of Lightstone Ventures III with $375 million in capital commitments, to invest in early-stage companies developing high impact the... |
| 14.09.2021 | After 3 big exits, Lightstone snags largest fund yet with $375M geared toward next biotechs, medtechs
How to Optimize In Vitro and In Vivo Data Analysis and Data Management in Drug Research | After seeing Ra Pharmaceuticals, Disarm Therapeutics and Tizona Therapeutics to exits last year, Lightstone Ventures is back with $375 million to plant a seed in early-stage biotech and medtech startups.
Lightstone's raise comes amid a bann... |
| 14.09.2021 | A not-so-secret, secret ingredient in Mailchimp’s new $12 billion valuation | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
Paid Content How data can accelerate growth and innovation From Deloitte
In a year when unicorn s... |
| 14.09.2021 | Lightstone Ventures Raises $375M Fund to Invest in Early Stage Biotech and Medtech Companies | What You Should Know:
– Lightstone Ventures today announced the closing of Lightstone Ventures III with $375M in capital commitments, to invest in early-stage companies developing high-impact therapeutics and technologies.
– The new fund wa... |
| 14.09.2021 | Lightstone Ventures’ raises $375M for its largest fund yet | - |
| 14.09.2021 | A not-so-secret, secret ingredient in Mailchimp’s new $12 billion valuation | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
Paid Content How to ensure your marketers stay dynamic and agile From Optimizely
In a year when u... |
| 05.02.2020 | Lightstone Completes $103 Million Series B | Lightstone has completed a Series B bond offering of $103 million on the Tel Aviv Stock Exchange.
The bonds were sold by Lightstone Enterprises Limited (LEI), a BVI-registered public company that is a wholly-owned entity of Lightstone. The ... |
| 18.10.2017 | Gemini Therapeutics closes $42.5M Series A for dry age-related macular degeneration therapy | Atlas Venture, Lightstone Ventures and OrbiMed co-led the Series A, according to a news release. They also took part in the seed round last year.
James McLaughlin, Gemini Therapeutics cofounder and CEO, said that the company focuses on pati... |
| 22.09.2017 | Venture Capital Firm Lightstone Ventures Raises $250M for Third Fund | Lightstone Ventures, a Boston, Menlo Park, Dublin, and Singapore-based global venture capital firm, raised $250m for Lightstone Ventures II, L.P. (LSV II).
With LSV II, an over-subscribed fund that exceeded its target of $200 million, Light... |
| 20.09.2017 | Lightstone Ventures Closes New Life Sciences Fund at $250 Million | MENLO PARK, Calif. and BOSTON, Sept. 20, 2017 (GLOBE NEWSWIRE) -- Lightstone Ventures (LSV), a leading global venture capital firm, today announced it has raised $250 million for Lightstone Ventures II, L.P. (LSV II). The firm also announce... |
| 20.09.2017 | Lightstone Ventures Closes New Life Sciences Fund at $250 Million | - |
| 06.12.2016 | Cerevance Raises $36M Funding from Lightstone Ventures | OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO:4502) and Lightstone Ventures today announced the launch of Cerevance, a neuroscience company focused on discovering and developing novel the... |
| 13.09.2016 | Lightstone Ventures Adds Susan M. Molineaux as Scientific Advisor | Lightstone Ventures has appointed Susan M. Molineaux, Ph.D. as Scientific Advisor.
In this role, she will assist the LSV biotechnology team with deal sourcing and due diligence.
Dr. Molineaux also continues to serve as the President, Chief ... |
| 18.02.2016 | Lightstone Ventures Closes US$50M Venture Capital Fund | Global venture capital firm Lightstone Ventures (LSV) closed a US$50m fund focused on investing in Singapore-based life sciences companies.
Limited Partners in Lightstone Singapore, L.P., include Temasek, an investment company based in Sing... |
| 18.02.2016 | Experienced med tech investor Lightstone Ventures closes $50M Singapore fund | - |
| 17.02.2016 | Lightstone Ventures closes $50m Singapore-focussed fund. Temasek, EDBI among investors | Premium
US-based lifesciences fund Lightstone Ventures (LSV), has closed a $50-million Singapore-focussed fund with investments from the corporate investment arm of the Singapore Economic Development Board – EDBI, and the state investment f... |
| 16.02.2016 | Stealth Stanford spinout Cala Health raises $18M for wearable device that treats hand and wrist tremors | Cala Health was founded two years ago by Stanford Biodesign 2012 fellow Kate Rosenbluth. However, in 2013 she won a $10,000 “Boomer” award for another company, Resido Medical, that is meant to treat essential tremor – a condition prevalent ... |
| 24.07.2015 | Daily funding roundup - July 24, 2015 | Northleaf Venture Catalyst Fund closed $300M; Voxel8 received $12M; AdAgility raised $1.6M
AdAgility, a provider of personalized, on-site and mobile, cross-selling solutions, raised $1.6 million to further accelerate its already impressive ... |
| 02.05.2014 | Lightstone Ventures Closes Life Sciences VC Fund at $172M | Life Sciences vc firm Lightstone Ventures (LSV) closed its first fund at $172m.
Lightstone Ventures, L.P., targets investment opportunities in early-stage biotechnology and medical device companies.
The fund has already made three investmen... |
| 01.05.2014 | VC Lightstone lands $172M fund with an eye on biotech startups | - |
| 01.05.2014 | Morgenthaler, ATV vets team up for new $172M early-stage life science venture capital fund | Carusi said in a statement that a lively IPO market, improvements at the FDA and interest from large corporate players to invest in and acquire life science companies has created a lot of promise in the sector, making it appealing for inves... |
| 09.01.2014 | FIRE1 Raises Series A Funding | FIRE1, a Dublin, Ireland-based developer of novel therapeutic devices, raised a Series A funding of undisclosed amount.
The company is incubated within The Foundry, a medical device incubator.
Backers included Covidien plc (NYSE: COV), Ligh... |
| - | Stealth Stanford spinout Cala Health raises $18M for wearable device that treats hand and wrist tremors | Stealth Bay Area medical device maker Cala Health looks to have closed out an $18 million Series A round, according to a regulatory filing. Investors in the company include Johnson & Johnson Development Corporation, Lux Capital and Ligh... |
| - | Morgenthaler, ATV vets team up for new $172M early-stage life science venture capital fund | Four general partners from Advanced Technology Ventures‘ and Morgenthaler Ventures‘ life science teams have joined forces to invest up to $172 million in biopharmaceutical and medical device startups.
Lightstone Ventures, led by Michael Car... |
| - | Gemini Therapeutics closes $42.5M Series A for dry age-related macular degeneration therapy | Fundus photo of macular scarring with normal blood vessels and optic nerve
Gemini Therapeutics has closed a Series A round to advance its precision medicine therapy for dry age-related macular degeneration. The Cambridge, Massachusetts comp... |
